Literature DB >> 21048823

Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008.

.   

Abstract

Year:  2009        PMID： 21048823      PMCID： PMC2928836          DOI： 10.1159/000188082

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  44 in total

Review 1.  Impact of vCJD on blood supply.

Authors:  Rainer Seitz; Friedger von Auer; Johannes Blümel; Reinhard Burger; Anne Buschmann; Klaus Dietz; Margarethe Heiden; Walter E Hitzler; Horst Klamm; Thomas Kreil; Hans Kretzschmar; Micha Nübling; Ruth Offergeld; Georg Pauli; Volkmar Schottstedt; Peter Volkers; Inga Zerr
Journal:  Biologicals       Date:  2007-02-21       Impact factor: 1.856

2.  A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment.

Authors:  Bjarne Krebs; Benedikt Bader; Juliane Klehmet; Eva Grasbon-Frodl; Wolfgang H Oertel; Inga Zerr; Sarah Stricker; Rolf Zschenderlein; Hans A Kretzschmar
Journal:  Acta Neuropathol       Date:  2007-06-19       Impact factor: 17.088

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Comparison of three monoclonal antibodies for use in immunohistochemical detection of bovine spongiform encephalopathy protease-resistant prion protein.

Authors:  Francisco J Salguero; Segundo Fayna Díaz-San; Alejandro Brun; María J Cano; Juan M Torres
Journal:  J Vet Diagn Invest       Date:  2006-01       Impact factor: 1.279

5.  The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

Authors:  P Brown; R G Rohwer; B C Dunstan; C MacAuley; D C Gajdusek; W N Drohan
Journal:  Transfusion       Date:  1998-09       Impact factor: 3.157

6.  Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.

Authors:  Vito Angelo Berardi; Franco Cardone; Angelina Valanzano; Mei Lu; Maurizio Pocchiari
Journal:  Transfusion       Date:  2006-04       Impact factor: 3.157

7.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody.

Authors:  C Korth; B Stierli; P Streit; M Moser; O Schaller; R Fischer; W Schulz-Schaeffer; H Kretzschmar; A Raeber; U Braun; F Ehrensperger; S Hornemann; R Glockshuber; R Riek; M Billeter; K Wüthrich; B Oesch
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

8.  Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.

Authors:  Simon Mead; Susan Joiner; Melanie Desbruslais; Jonathan A Beck; Michael O'Donoghue; Peter Lantos; Jonathan D F Wadsworth; John Collinge
Journal:  Arch Neurol       Date:  2007-12

9.  [Report on notifications pursuant to Section 21 German Transfusion Act for 2005 and 2006].

Authors:  B Haschberger; O Henseler; J Hesse; M Heiden; R Seitz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2008-03       Impact factor: 1.513

10.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103
View more
  4 in total

1.  Still in Focus: Assessment of Blood-Borne Pathogens.

Authors:  Rainer Seitz; Margarethe Heiden; Ruth Offergeld; Reinhard Burger
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Blood transfusion and spread of variant Creutzfeldt-Jakob disease.

Authors:  Klaus Dietz; Günter Raddatz; Jonathan Wallis; Norbert Müller; Inga Zerr; Hans-Peter Duerr; Hans Lefèvre; Erhard Seifried; Johannes Löwer
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 3.  The 'precautionary principle' as a guide for future drug development.

Authors:  S Alban
Journal:  Eur J Clin Invest       Date:  2005-03       Impact factor: 4.686

Review 4.  Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.

Authors:  Robert Klamroth; Albrecht Gröner; Toby L Simon
Journal:  Transfusion       Date:  2013-09-30       Impact factor: 3.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.